Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
National Institute on Drug Abuse (NIDA) |
---|---|
Information provided by: | National Institute on Drug Abuse (NIDA) |
ClinicalTrials.gov Identifier: | NCT00496951 |
Symptoms of Neonatal Abstinence Syndrome (NAS) can be attributed largely to dysfunction of the autonomic nervous system in opiate exposed neonates.
Vagal tone is a readily available measure of autonomic nervous system functioning. NAS is a widely variable disorder with poorly understood pathophysiology; while all opiate exposed infants will exhibit some signs and symptoms of NAS, only approximately ½ have severe enough symptoms to require pharmacologic therapy. This research seeks to determine the relationship between infant vagal tone and NAS severity. The determination of a link between newborn vagal tone and NAS severity could result in the prediction of infants at risk for severe NAS and provide these infants and mothers with intensified services and early treatment, thereby shortening the course of NAS in the infant.
Condition | Intervention |
---|---|
Neonatal Abstinence Syndrome Vagal Tone |
Device: Vagal tone assessment |
Study Type: | Observational |
Study Design: | Cohort, Prospective |
Official Title: | Vagal Tone and Neonatal Abstinence Syndrome |
Enrollment: | 65 |
Study Start Date: | September 2006 |
Study Completion Date: | September 2008 |
Ages Eligible for Study: | up to 1 Day |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Drug exposed infants
Inclusion Criteria:
Exclusion Criteria:
United States, Maryland | |
Johns Hopkins Bayview Medical Center | |
Baltimore, Maryland, United States, 21224 |
Principal Investigator: | Lauren M Jansson, MD | Johns Hopkins University |
Responsible Party: | Johns Hopkins University School of Medicine ( Lauren Jansson / Assistant Prfessor of Pediatrics ) |
Study ID Numbers: | 6468, NIDA R01DA019934, DPMCDA |
Study First Received: | July 5, 2007 |
Last Updated: | April 15, 2009 |
ClinicalTrials.gov Identifier: | NCT00496951 History of Changes |
Health Authority: | United States: Institutional Review Board; United States: Federal Government |
Neonatal abstinence syndrome Methadone Vagal tone |
Methadone Mental Disorders Neonatal Abstinence Syndrome |
Substance-Related Disorders Disorders of Environmental Origin Infant, Newborn, Diseases |
Pathologic Processes Disease Mental Disorders Neonatal Abstinence Syndrome |
Syndrome Substance-Related Disorders Disorders of Environmental Origin Infant, Newborn, Diseases |